Evidenz
[1] Originalpublikation
Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach.
Chest, 2010
[2] Validierung
Olesen JB, Lip GYH, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. CHA₂DS₂-VASc reliably identifies patients who are truly low risk.
BMJ, 2011
[3] Leitlinie
Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation (developed with EACTS). This app uses the guideline-era sex-aware CHA₂DS₂-VASc score categories.
European Heart Journal, 2021
[4] Weitere Quelle
Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
European Heart Journal, 2024
Zuletzt geprüft: 2026-09
Fehler in diesem Rechner melden